JMIR Cancer. 2025 Oct 30;11:e79956. doi: 10.2196/79956.
ABSTRACT
BACKGROUND: Although the use of telehealth has declined since the pandemic, it remains a popular mode of care delivery across the cancer care continuum. Understanding telehealth in the context of cancer care is essential, as its benefits and challenges may differ among diverse population groups and geographic areas.
OBJECTIVE: This study aimed to examine patterns of telehealth utilization across the cancer care continuum and to identify factors associated with the receipt of telehealth in a large patient population. This study also aimed to assess the telehealth’s impact on key health care delivery outcomes.
METHODS: We used an annualized retrospective cohort design using patient data from the Johns Hopkins Health System (JHHS), a large regional academic health center in Maryland. The study analyzed electronic health record (EHR) data covering the period from January 1, 2019, to December 31, 2023. Chronic conditions were defined through the Johns Hopkins Adjusted Clinical Groups (ACG) System, which identifies comorbidities based on the International Classification of Diseases, Tenth Revision, Clinical Modification, codes in the electronic health record. In addition, we used publicly available geospatial data (eg, internet connectivity, rural-urban commuting area) to assess telehealth receipt associations. Statistical modeling, including generalized estimating equations, was used to evaluate variations in telehealth utilization and outcomes.
RESULTS: A total of 124,974 adult patients receiving cancer-related care at Johns Hopkins Health System were identified during the study period. Telehealth users were significantly older (52.2% aged ≥65 years, 19,942 patients) compared to nonusers (48.7%, 42,209 patients). In addition, these users were more likely to be male (45.4%, 17,365 patients vs 40.2%, 34,839 patients) and to identify as White (70.8%, 27,071 patients vs 64.7%, 56,122 patients). Telehealth users also had a higher prevalence of comorbidities, with 61.5% (23,503 patients) reporting 3 or more chronic conditions compared to 38.0% (33,000 patients) among nonusers. A positive correlation was noted between rural-urban commuting area codes and telehealth service utilization (ρ=0.36; P<0.05), indicating higher usage in more rural areas. Conversely, average maximum download and upload speeds showed an inverse relationship with telehealth utilization (ρ=-0.22; P<0.05; and ρ=-0.34; P<0.05, respectively). Adjusted analyses indicated that concurrent telehealth use was associated with reduced odds of emergency department visits (0.916, 95% CI 0.884-0.948) and hospitalizations (0.830, 95% CI 0.799-0.863), acknowledging the potential influence of residual confounding.
CONCLUSIONS: Telehealth has emerged as a crucial mode of care delivery for patients with complex conditions such as cancer. Understanding usage patterns and factors influencing telehealth across the cancer care continuum, including geographic barriers, is vital to optimizing its implementation and ensuring health care systems meet the diverse needs of patients with cancer in a value-based care environment.
PMID:41166738 | DOI:10.2196/79956
